toxCSM: comprehensive prediction of small molecule toxicity profiles
Related Experiment Video
Updated: Aug 31, 2025

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
Published on: March 14, 2019
Alex G C de Sá1,2,3,4, Yangyang Long2,3,5, Stephanie Portelli1,2,3
1School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane City, Queensland, 4072, Australia.
Abstract:
Drug discovery is a lengthy, costly and high-risk endeavour that is further convoluted by high attrition rates in later development stages. Toxicity has been one of the main causes of failure during clinical trials, increasing drug development time and costs. To facilitate early identification and optimisation of toxicity profiles, several computational tools emerged aiming at improving success rates by timely pre-screening drug candidates. Despite these efforts, there is an increasing demand for platforms capable of assessing both environmental as well as human-based toxicity properties at large scale. Here, we present toxCSM, a comprehensive computational platform for the study and optimisation of toxicity profiles of small molecules. toxCSM leverages on the well-established concepts of graph-based signatures, molecular descriptors and similarity scores to develop 36 models for predicting a range of toxicity properties, which can assist in developing safer drugs and agrochemicals. toxCSM achieved an Area Under the Receiver Operating Characteristic (ROC) Curve (AUC) of up to 0.99 and Pearson's correlation coefficients of up to 0.94 on 10-fold cross-validation, with comparable performance on blind test sets, outperforming all alternative methods. toxCSM is freely available as a user-friendly web server and API at http://biosig.lab.uq.edu.au/toxcsm.
Insights
Toxicity is a major cause of drug development failure. The toxCSM platform uses computational models to predict toxicity, aiding in the development of safer drugs and agrochemicals.
Area of Science:
- Computational toxicology
- Drug discovery and development
- Environmental and human health risk assessment
Background:
- Drug discovery is expensive and prone to failure, with toxicity being a primary reason for clinical trial attrition.
- Existing computational tools for toxicity prediction are limited in scope and scale.
- There is a need for comprehensive platforms to assess human and environmental toxicity early in drug development.
Purpose of the Study:
- To present toxCSM, a computational platform for studying and optimizing the toxicity profiles of small molecules.
- To provide a tool for early identification and optimization of toxicity, thereby reducing drug development costs and timelines.
- To develop predictive models for a wide range of toxicity properties relevant to drug and agrochemical safety.
Main Methods:
- Leveraging graph-based signatures, molecular descriptors, and similarity scores.
- Developing 36 predictive models for various toxicity endpoints.
- Utilizing 10-fold cross-validation and blind test sets for performance evaluation.
Main Results:
- Achieved high predictive performance with Area Under the Receiver Operating Characteristic (ROC) Curve (AUC) up to 0.99 and Pearson's correlation coefficients up to 0.94.
- Demonstrated superior performance compared to alternative methods on both cross-validation and blind test sets.
- Developed a comprehensive suite of models for diverse toxicity assessments.
Conclusions:
- toxCSM offers a robust computational solution for predicting small molecule toxicity.
- The platform can significantly assist in developing safer drugs and agrochemicals by enabling early toxicity profiling.
- toxCSM is accessible via a user-friendly web server and API for broad scientific use.
More Related Videos
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Related Concept Videos
Drug Discovery: Overview
Predicting Reaction Outcomes
Mutagenicity and Carcinogenicity